Trials in Houston, Texas
Here are the top 10 medical studies for prostate cancer in Houston, Texas
Popular Filters
Phase 3 Trials
PARP Inhibitor
Niraparib + Abiraterone Acetate + Prednisone for Metastatic Prostate Cancer
Recruiting1 awardPhase 3
Houston, Texas
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Little Rock, Arkansas
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
AKT Inhibitor
Capivasertib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
Houston, Texas
This trial will compare the efficacy of capivasertib+abiraterone+androgen deprivation therapy to placebo+abiraterone+androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC) whose tumours are PTEN-deficient. The primary endpoint is radiographic progression-free survival.
Trials With No Placebo
Monoclonal Antibodies
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody for Advanced Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing two new drugs that help the immune system fight cancer. It targets adults with advanced cancers that haven't responded to other treatments. The drugs work by blocking proteins that usually prevent the immune system from attacking cancer cells.
XL092 + Immunotherapy for Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new drug called XL092 by itself and with two other drugs, atezolizumab and avelumab. It targets patients with advanced solid tumors who may not respond to current treatments. XL092 aims to stop cancer cells from growing, while atezolizumab and avelumab help the immune system fight the cancer. Atezolizumab is approved for various cancers, including breast and urothelial carcinoma, and has shown efficacy in combination with chemotherapy.
Hormone Therapy
Standard Therapy + Surgery/Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Little Rock, Arkansas
This trial is testing whether adding surgery or radiation therapy to standard treatment for prostate cancer that has spread to other parts of the body lowers the chance of the cancer growing or spreading.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.